Skip to main content

ROYCE & ASSOCIATES LP

Position in AXSM — Axsome Therapeutics, Inc.

CIK 906304 New York, NY

Position in AXSM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$22,284,105
+$6,393,352 QoQ
Shares Held
91,041
-3.2% QoQ
Ownership
0.174%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#75
of 500 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AXSM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYCE & ASSOCIATES LP holds $280,073,421 across 31 Biotechnology names. AXSM ranks #3 (8.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 AXSM
Axsome Therapeutics, Inc.
This page
91,041 $22,284,105

All Filings in AXSM

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $22,284,105 91,041
2026-03-31 $15,890,753 94,017
2025-12-31 $17,171,264 94,017
2025-09-30 $6,805,572 56,036
2025-06-30 $2,688,773 25,757
2025-03-31 $3,528,873 30,257
2024-12-31 $3,130,570 37,000
2024-09-30 $2,022,075 22,500
2024-06-30 $1,046,500 13,000
2024-03-31 $1,037,400 13,000
2021-06-30 $1,369,438 20,300
2021-03-31 $1,455,134 25,700
2020-12-31 $2,093,779 25,700
2020-09-30 $1,831,125 25,700
2020-06-30 $2,114,596 25,700
2020-03-31 $2,359,083 40,100